Rice Hall James & Associates’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-276,847
| Closed | -$4.91M | – | 267 |
|
|
2022
Q2 | $4.91M | Sell |
276,847
-160,353
| -37% | -$2.84M | 0.24% | 86 |
|
|
2022
Q1 | $8.9M | Sell |
437,200
-267,001
| -38% | -$5.44M | 0.35% | 71 |
|
|
2021
Q4 | $13.2M | Sell |
704,201
-48,837
| -6% | -$912K | 0.47% | 53 |
|
|
2021
Q3 | $14.9M | Sell |
753,038
-46,260
| -6% | -$913K | 0.55% | 55 |
|
|
2021
Q2 | $18.9M | Sell |
799,298
-126,530
| -14% | -$2.99M | 0.67% | 51 |
|
|
2021
Q1 | $21.9M | Buy |
925,828
+4,903
| +0.5% | +$116K | 0.72% | 45 |
|
|
2020
Q4 | $18.4M | Sell |
920,925
-187,294
| -17% | -$3.75M | 0.65% | 48 |
|
|
2020
Q3 | $23.1M | Buy |
1,108,219
+111,601
| +11% | +$2.32M | 0.93% | 34 |
|
|
2020
Q2 | $17.4M | Sell |
996,618
-37,203
| -4% | -$651K | 0.75% | 45 |
|
|
2020
Q1 | $16.9M | Sell |
1,033,821
-22,565
| -2% | -$368K | 0.94% | 32 |
|
|
2019
Q4 | $21.7M | Sell |
1,056,386
-159,243
| -13% | -$3.28M | 0.74% | 43 |
|
|
2019
Q3 | $14M | Sell |
1,215,629
-45,061
| -4% | -$517K | 0.5% | 83 |
|
|
2019
Q2 | $16.6M | Buy |
1,260,690
+69,549
| +6% | +$915K | 0.55% | 65 |
|
|
2019
Q1 | $18M | Buy |
1,191,141
+259,015
| +28% | +$3.92M | 0.58% | 57 |
|
|
2018
Q4 | $16M | Buy |
932,126
+366,184
| +65% | +$6.29M | 0.58% | 59 |
|
|
2018
Q3 | $8.34M | Buy |
565,942
+129,432
| +30% | +$1.91M | 0.3% | 101 |
|
|
2018
Q2 | $10.4M | Buy |
436,510
+53,530
| +14% | +$1.28M | 0.38% | 91 |
|
|
2018
Q1 | $9.79M | Buy |
382,980
+50,393
| +15% | +$1.29M | 0.38% | 93 |
|
|
2017
Q4 | $6.14M | Buy |
332,587
+276,123
| +489% | +$5.1M | 0.24% | 105 |
|
|
2017
Q3 | $592K | Buy |
+56,464
| New | +$592K | 0.03% | 254 |
|